HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage.

Abstract
Although 17beta-estradiol (E2) attenuates the alterations in Kupffer cells and splenic macrophages (MPhi) cytokine production following trauma-hemorrhage, the mechanism by which this occurs remains unknown. Utilizing a cell-impermeable E2 conjugated with BSA (E2-BSA), we examined the non-genomic effects of E2 on the above two cell population cytokine production, MAPK and transcription factors activation following trauma-hemorrhage. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean BP 40 mmHg for 90 min, then resuscitation). E2, E2-BSA (1 mg/kg E2) with or without an estrogen receptor antagonist (ICI 182,780), or vehicle was administrated during resuscitation. Two hrs thereafter, Kupffer cells and SMPhi production of IL-6, TNF-alpha, and IL-10, activation of MAPK (p38, ERK-1/2, and JNK), and transcription factors (NF-kappaB and AP-1) were determined. IL-6, TNF-alpha, and IL-10 productive capacity, MAPK, and transcription factors activation increased in Kupffer cells while they decreased in SMPhi following trauma-hemorrhage. However, E2 administration normalized all of these alterations. Although E2-BSA also attenuated the alterations in cytokine production/transcription factors, the values were higher in Kupffer cells and lower in SMPhi compared to shams. In contrast, E2-BSA prevented trauma-hemorrhage-mediated changes in MAPK activation to the same extent as E2. Co-administration of ICI 182,780 abolished E2-BSA effects. Although some MAPK inhibitors suppressed cytokine production, the inhibitor effectiveness was dependent on cytokine, cell type and animal condition (trauma-hemorrhage or sham). Thus, E2 effects on Kupffer cells and SMPhi cytokine production and transcription factors activation following trauma-hemorrhage are mediated at least in part via non-genomic pathway and these non-genomic effects are likely mediated via MAPK pathways.
AuthorsTakao Suzuki, Huang-Ping Yu, Ya-Ching Hsieh, Mashkoor A Choudhry, Kirby I Bland, Irshad H Chaudry
JournalJournal of cellular physiology (J Cell Physiol) Vol. 214 Issue 3 Pg. 662-72 (Mar 2008) ISSN: 1097-4652 [Electronic] United States
PMID17786973 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright(c) 2007 Wiley-Liss, Inc.
Chemical References
  • Cytokines
  • Enzyme Inhibitors
  • Estrogens
  • Lipopolysaccharides
  • NF-kappa B
  • Transcription Factor AP-1
  • DNA
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Cytokines (biosynthesis)
  • DNA (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Estrogens (pharmacology)
  • Extracellular Signal-Regulated MAP Kinases (antagonists & inhibitors, metabolism)
  • Genome
  • Hemorrhage (chemically induced, pathology)
  • JNK Mitogen-Activated Protein Kinases (antagonists & inhibitors, metabolism)
  • Kupffer Cells (cytology, drug effects, enzymology)
  • Lipopolysaccharides (pharmacology)
  • Macrophages (drug effects, enzymology, metabolism)
  • Male
  • NF-kappa B (metabolism)
  • Phosphorylation (drug effects)
  • Protein Binding (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Spleen (cytology, drug effects, enzymology)
  • Transcription Factor AP-1 (metabolism)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: